Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10-year experience

被引:65
|
作者
Liu, Juan [1 ]
Yu, Huapeng [1 ]
Sun, Xicai [1 ]
Wang, Dehui [1 ]
Gu, Yurong [1 ]
Liu, Quan [1 ]
Wang, Huan [1 ]
Han, Wade [2 ]
Fry, Allison [2 ]
机构
[1] Fudan Univ, Shanghai Med Coll, Eye Ear Nose & Throat Hosp, Dept Otolaryngol, 83 Fenyang Rd, Shanghai, Peoples R China
[2] Florida Ear Nose Throat & Facial Plast Surg, Kissimmee, FL USA
基金
中国国家自然科学基金;
关键词
Nasopharyngeal carcinoma; Nasopharyngectomy; Endoscopic skull base surgery; INTENSITY-MODULATED RADIOTHERAPY; SKULL BASE SURGERY; PROGNOSTIC-FACTORS; SURGICAL SALVAGE; HONG-KONG; REIRRADIATION; CANCER; MANAGEMENT; MELANOMA; SURVIVAL;
D O I
10.1007/s10147-017-1143-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our aim was to review the outcomes of endoscopic nasopharyngectomy performed on a large series of patients with residual or recurrent nasopharyngeal carcinomas and to identify the prognostic factors. Ninety-one patients with residual (10) and recurrent (81) nasopharyngeal carcinomas who underwent endoscopic nasopharyngectomy were enrolled in our study. Clinical information including gender, age, medical history, symptoms, radiographic findings, tumor stage, treatment, recurrence time, postoperative pathological examination, complications, and outcomes at last follow-up visit was collected. The survival curves and multivariate survival analysis were analyzed using the Kaplan-Meier and Cox proportional hazards model. Our study included 71 men and 20 women with a median age of 51 years. The lesions were staged as follows: rT1, 30; rT2, 13; rT3, 29; and rT4, 19. No serious operative or postoperative complication was observed. The median follow-up period was 23 months (range, 4-109 months). Tumor necrosis was identified in 40 of 91 patients. At the last follow-up, 42 patients were free of disease, 10 were alive with disease, and 39 had died. At 2- and 5-year follow-up, the overall survival rates were 64.8% and 38.3%, respectively; the disease-free survival rates were 57.5% and 30.2%, respectively, for the two periods. Multivariate analysis showed that T classification (P = 0.02) and tumor necrosis (P = 0.024) were independent risk factors. Endoscopic nasopharyngectomy is a feasible and effective surgical treatment for recurrent and residual nasopharyngeal carcinomas.
引用
收藏
页码:834 / 842
页数:9
相关论文
共 50 条
  • [31] Endoscopic Nasopharyngectomy and its Role in Managing Locally Recurrent Nasopharyngeal Carcinoma
    Ong, Yew Kwang
    Solares, C. Arturo
    Lee, Steve
    Snyderman, Carl H.
    Fernandez-Miranda, Juan
    Gardner, Paul A.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2011, 44 (05) : 1141 - +
  • [32] SURGICAL SALVAGE NASOPHARYNGECTOMY FOR RECURRENT NASOPHARYNGEAL CARCINOMA: A MULTIVARIATE ANALYSIS OF PROGNOSTIC FACTORS
    Vlantis, Alexander C.
    Chan, Hing Sang
    Tong, Michael C. F.
    Yu, Brian K. H.
    Kam, K. M.
    van Hasselt, C. Andrew
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (08): : 1126 - 1131
  • [33] Endoscopic Nasopharyngectomy Combined With Internal Carotid Artery Pretreatment for Recurrent Nasopharyngeal Carcinoma
    Wang, Zhi-Qiang
    Xie, Yu-Long
    Liu, You-Ping
    Zou, Xiong
    Chen, Jin-Hua
    Hua, Yi-Jun
    Gu, Yang-Kui
    Ouyang, Yan-Feng
    Yu, Zi-Kun
    Sun, Rui
    Huang, Pei-Yu
    Chen, Ming-Yuan
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2022, 166 (03) : 490 - 497
  • [34] Salvage endoscopic nasopharyngectomy and intensity-modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma
    Zou, Xiong
    Han, Fei
    Ma, Wen-Juan
    Deng, Man-Quan
    Jiang, Rou
    Guo, Ling
    Liu, Qing
    Mai, Hai-Qiang
    Hong, Ming-Huang
    Chen, Ming-Yuan
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (08): : 1108 - 1115
  • [35] Impact of resection margin status on outcome after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma
    Chan, Jimmy Yu Wai
    Wei, William Ignace
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E594 - E599
  • [36] Clinical outcomes of residual or recurrent nasopharyngeal carcinoma treated with endoscopic nasopharyngectomy plus chemoradiotherapy or with chemoradiotherapy alone: a retrospective study
    Weng, Jingjin
    Wei, Jiazhang
    Si, Jinyuan
    Qin, Yangda
    Li, Min
    Liu, Fei
    Si, Yongfeng
    Su, Jiping
    PEERJ, 2017, 5
  • [37] Innovative application of internal carotid artery embolization in salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma: A case-matched comparison
    Li, Wanpeng
    Liu, Qiang
    Wang, Huan
    Zhang, Huangkang
    Liu, Quan
    Hu, Li
    Li, Houyong
    Dai, Jiong
    Sun, Xicai
    Yu, Hongmeng
    Wang, Dehui
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2022, 12 (06) : 838 - 848
  • [38] LINAC-based Fractionated Stereotactic Radiotherapy for Residual and Recurrent Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy: A 10-year Experience
    Lau, T. T. S.
    Chan, L. L.
    Yu, E. L. M.
    Lai, J. W. Y.
    Yuen, K. T.
    Cheng, A. C. K.
    HONG KONG JOURNAL OF RADIOLOGY, 2020, 23 (02): : 93 - 105
  • [39] Preliminary Efficacy Report and Prognosis Analysis of Endoscopic Endonasal Nasopharyngectomy for Recurrent Nasopharyngeal Carcinoma
    Peng, Zhouying
    Wang, Yumin
    Wang, Yaxuan
    Fan, Ruohao
    Gao, Kelei
    Zhang, Hua
    Xie, Zhihai
    Jiang, Weihong
    FRONTIERS IN SURGERY, 2021, 8
  • [40] Salvage surgery in nasopharyngeal Cancer: Unraveling the efficacy of transnasal endoscopic nasopharyngectomy for advanced stage recurrent tumors
    Bozkurt, Gulpembe
    Zanoni, Mario Turri
    Ferrari, Marco
    Ioppi, Alessandro
    Peker, Sinem Kara
    Elhassan, Hasan
    Anarat, Melis Ece Arkan
    Yilmaz, Yetkin Zeki
    Taboni, Stefano
    Ruaro, Alessandra
    Rampinelli, Vittorio
    Mattavelli, Davide
    Schreiber, Alberto
    Vinciguerra, Alessandro
    Verillaud, Benjamin
    Battaglia, Paolo
    Piazza, Cesare
    Herman, Philippe
    Castelnuovo, Paolo
    Nicolai, Piero
    Vural, Alperen
    ORAL ONCOLOGY, 2024, 159